Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

418463

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hidradenitis Suppurativa
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps NHS England takes to assess the health and social care needs of patients with hidradenitis suppurativa; and what assessment he has made of the ability of the NHS to deliver efficient diagnosis and access to specialist care for such patients.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	10010
	answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>NHS England works in partnership with local commissioners and providers to ensure people with long-term conditions, such as hidradenitis suppurativa (HS), are supported to live healthily and independently and are empowered to take better control over the care they receive.</p><p> </p><p> </p><p> </p><p>The majority of patients with HS can be managed through routine access to primary and secondary care, including dermatology clinics, which is responsibility of the local National Health Service commissioners. Treatment and management of the condition involves antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe.</p><p> </p><p> </p><p> </p><p>For those patients with the more serious forms of HS, referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions, including HS, and has set out what providers must have in place in order to offer specialist dermatology care. This supports equity of access to a high quality service for patients wherever they live. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found by viewing the specialised dermatology service specification at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 10011 question first answered 16/09/2015 11:46:53 answering member 3918 label Biography information for Jane Ellison
	tabling member	1538 label Biography information for Rosie Cooper

418464

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hidradenitis Suppurativa
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what progress has been made by NHS England on the production of a commissioning policy for treatments associated with hidradenitis suppurativa; what the proposed scope of that policy is; and when he expects that policy to have been fully developed.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	10011
	answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>NHS England works in partnership with local commissioners and providers to ensure people with long-term conditions, such as hidradenitis suppurativa (HS), are supported to live healthily and independently and are empowered to take better control over the care they receive.</p><p> </p><p> </p><p> </p><p>The majority of patients with HS can be managed through routine access to primary and secondary care, including dermatology clinics, which is responsibility of the local National Health Service commissioners. Treatment and management of the condition involves antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe.</p><p> </p><p> </p><p> </p><p>For those patients with the more serious forms of HS, referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions, including HS, and has set out what providers must have in place in order to offer specialist dermatology care. This supports equity of access to a high quality service for patients wherever they live. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found by viewing the specialised dermatology service specification at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 10010 question first answered 16/09/2015 11:46:53 answering member 3918 label Biography information for Jane Ellison
	tabling member	1538 label Biography information for Rosie Cooper

418447

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Statins
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take steps to ensure patients prescribed statins can make a choice on what type of statins they receive.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10020
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Decisions regarding the appropriateness of a particular treatment, including statins, should be made by clinicians in partnership with patients. The individual circumstances of each patient should be taken into account, alongside their medical history, needs and preferences.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 10:04:02 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon

418448

	registered interest
	date	11/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Smoking
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what information his Department holds on how many people of what age ranges gave up smoking in each of the last five years.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10021
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>The Health and Social Care Information Centre collects this information on behalf of the Department and it is made publicly available at the following web addresses:</p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB00417/nhs-stop-smok-serv-eng-2010-2011-tab.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB00417/nhs-stop-smok-serv-eng-2010-2011-tab.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB07011/stat-stop-smok-eng-apr-11-mar-12-tab1.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB07011/stat-stop-smok-eng-apr-11-mar-12-tab1.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB12228/stat-stop-smok-serv-eng-apr-12-mar-13-tab1.xls" target="_blank">http://www.hscic.gov.uk/catalogue/PUB12228/stat-stop-smok-serv-eng-apr-12-mar-13-tab1.xls</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB14610/stat-stop-smok-serv-eng-apr-13-mar-14-tab.xlsx" target="_blank">http://www.hscic.gov.uk/catalogue/PUB14610/stat-stop-smok-serv-eng-apr-13-mar-14-tab.xlsx</a></p><p> </p><p> </p><p> </p><p><a href="http://www.hscic.gov.uk/catalogue/PUB18002/stat-stop-smok-serv-eng-annual-1415.xlsx" target="_blank">http://www.hscic.gov.uk/catalogue/PUB18002/stat-stop-smok-serv-eng-annual-1415.xlsx</a></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 10:05:51 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon

418711

	registered interest
	date	14/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Donors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to promote the donation of blood, organs and other organic materials.
	tabling member constituency	Bishop Auckland
	tabling member printed	Helen Goodman
	uin	10111
	answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>NHS Blood and Transplant (NHSBT) is the organ donation organisation for the United Kingdom and is funded by the Department and the Devolved Administrations. Its remit also includes the provision of a reliable efficient supply of blood in England and North Wales, and providing tissues to the National Health Service.</p><p> </p><p> </p><p> </p><p>NHSBT actively campaigns to promote public awareness about the importance of organ and tissue donation and transplantation and to encourage people to join the NHS Organ Donor Register (ODR). Underpinning NHSBT’s work to promote organ donation is encouraging people to join the ODR and then to let their loved ones know that they have made a decision to donate. Encouraging this conversation is important as families are more likely to agree to donation if they know that is what their loved one wanted.</p><p> </p><p> </p><p> </p><p>The Department has also worked to raise general awareness of persistent inequalities people from a Black, Asian and Minority Ethnic (BAME) background face when trying to find a suitable bone marrow or organ donor and supports the work of the National BAME Transplant Alliance. Launched in 2012, this group helps to coordinate the work of BAME organisations promoting donation.</p><p> </p><p> </p><p> </p><p>The UK’s health administrations, many charities, community groups and hospitals also work hard to promote organ and tissue donation and NHSBT work collaboratively with them wherever possible.</p><p> </p><p> </p><p> </p><p>NHSBT regularly campaigns to encourage more of the eligible population, including from the BAME community to donate blood. Although blood stocks are currently in a healthy position, there is always a need for new donors to fill the gaps left by existing donors who are no longer able to give blood - to ensure that we have the right mix of blood groups to match patients’ needs. NHSBT co-ordinates local and national awareness campaigns, such as the current ‘Bleed for England’ campaign, which are intended to motivate thousands of people to start donating blood.</p><p> </p><p> </p><p> </p><p>In addition, the Department funds the national Gamete Donation Trust through a contract to provide a range of services to promote gamate donation and support the recruitment and retention of egg and sperm donors, which helps infertile couples.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/09/2015 14:39:02 answering member 3918 label Biography information for Jane Ellison
	tabling member	1484 label Biography information for Helen Goodman

418712

	registered interest
	date	14/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment his Department has made of the trends in the prevalence of diabetes; and if he will make a statement.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	10120
	answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>Diagnosed diabetes prevalence is taken from the Quality and Outcomes Framework (QOF) and represents all patients who have been diagnosed with diabetes and included on GP registers.</p><p> </p><p> </p><p> </p><p>Diabetes prevalence is increasing. Diagnosed diabetes prevalence has increased from 2.3 million (5.3%) in 2009/10 to 2.8 million (6.2%) in 2013/14; an increase of nearly half a million people.</p><p> </p><p> </p><p> </p><p>Public Health England’s diabetes prevalence model estimates total diabetes prevalence for England and for all local authorities and clinical commissioning groups (CCG) in England. The model reflects the prevalence of diabetes (diagnosed and undiagnosed) and adjusts for the age, sex, ethnic group and deprivation pattern of the local population.</p><p> </p><p> </p><p> </p><p>The estimated total diabetes prevalence using the diabetes prevalence model is 7.5% in 2014.</p><p> </p><p> </p><p> </p><p>If current trends continue then we estimate that by 2030 there will be over 4 million people with diabetes. This represents 8.8% of the population aged 16 years and over.</p><p> </p><p> </p><p> </p><p>This data is publically available on the Healthier Lives website at:</p><p> </p><p> </p><p> </p><p><a href="http://healthierlives.phe.org.uk/topic/diabetes" target="_blank">http://healthierlives.phe.org.uk/topic/diabetes</a></p><p> </p><p> </p><p> </p><p>The website also provides diagnosed prevalence at the CCG level.</p><p> </p><p> </p><p> </p><p>Tackling diabetes is of great concern to this Government. Building on the National Diabetes Prevention Programme, the Department is developing its plans to improve outcomes for those at risk of and with diabetes. These will be announced in due course.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 10181 question first answered 17/09/2015 15:53:59 answering member 3918 label Biography information for Jane Ellison
	tabling member	308 label Biography information for Mr Jim Cunningham

348267

	registered interest
	date	03/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion: Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent estimate he has made of the cost to the public purse of NHS abortion services from May 2010 to April 2015.
	tabling member constituency	North Antrim
	tabling member printed	Ian Paisley
	uin	1015
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>Information about expenditure on termination of pregnancy services is not collected centrally.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2015 11:56:55 answering member 3918 label Biography information for Jane Ellison
	tabling member	4129 label Biography information for Ian Paisley

418702

	registered interest
	date	14/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Visitors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many health visitors were employed in (a) 2011-12, (b) 2012-13, (c) 2013-14 and (d) 2014-15.
	tabling member constituency	Dunfermline and West Fife
	tabling member printed	Douglas Chapman
	uin	10170
	answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>The table below shows the number of full time equivalent health visitors employed in England at the mid-point in each year from 2011 to 2014, and the latest available figure in 2015. Data from 2012 onwards is taken from the Health Visitor Minimum Data Set (HV-MDS) which commenced in April 2012 and also includes data for health visitors employed by organisations that do not use Electronic Staff record (ESR) but do provide NHS-funded services, such as local authorities.</p><p> </p><p> </p><p> </p><p>Full time equivalent figures are used as this is the most accurate measure of service capacity.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>30 September 2011 <sup>1</sup></p></td><td><p>30 September 2012 <sup>2</sup></p></td><td><p>30 September 2013</p></td><td><p>30 September 2014</p></td><td><p>31 May 2015</p></td></tr><tr><td><p>7,941</p></td><td><p>8,678</p></td><td><p>9,550</p></td><td><p>10,800</p></td><td><p>11,850</p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source:</em> Health and Social Care Information Centre NHS Hospital and Community health service monthly workforce statistics</p><p> </p><p><em> </em></p><p> </p><p><em>Notes:</em></p><p> </p><p>1. The data for 2011 covers only those health visitors on the ESR.</p><p> </p><p>2. The figure for September 2012 is different from the published figure due to a known over count (of 14).</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/09/2015 15:56:12 answering member 3918 label Biography information for Jane Ellison
	tabling member	4402 label Biography information for Douglas Chapman

418704

	registered interest
	date	14/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment his Department has made of the prevalence of diabetes; and if he will make a statement.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	10181
	answer	answer is ministerial correction date of answer 17/09/2015 answer text <p>Diagnosed diabetes prevalence is taken from the Quality and Outcomes Framework (QOF) and represents all patients who have been diagnosed with diabetes and included on GP registers.</p><p> </p><p> </p><p> </p><p>Diabetes prevalence is increasing. Diagnosed diabetes prevalence has increased from 2.3 million (5.3%) in 2009/10 to 2.8 million (6.2%) in 2013/14; an increase of nearly half a million people.</p><p> </p><p> </p><p> </p><p>Public Health England’s diabetes prevalence model estimates total diabetes prevalence for England and for all local authorities and clinical commissioning groups (CCG) in England. The model reflects the prevalence of diabetes (diagnosed and undiagnosed) and adjusts for the age, sex, ethnic group and deprivation pattern of the local population.</p><p> </p><p> </p><p> </p><p>The estimated total diabetes prevalence using the diabetes prevalence model is 7.5% in 2014.</p><p> </p><p> </p><p> </p><p>If current trends continue then we estimate that by 2030 there will be over 4 million people with diabetes. This represents 8.8% of the population aged 16 years and over.</p><p> </p><p> </p><p> </p><p>This data is publically available on the Healthier Lives website at:</p><p> </p><p> </p><p> </p><p><a href="http://healthierlives.phe.org.uk/topic/diabetes" target="_blank">http://healthierlives.phe.org.uk/topic/diabetes</a></p><p> </p><p> </p><p> </p><p>The website also provides diagnosed prevalence at the CCG level.</p><p> </p><p> </p><p> </p><p>Tackling diabetes is of great concern to this Government. Building on the National Diabetes Prevention Programme, the Department is developing its plans to improve outcomes for those at risk of and with diabetes. These will be announced in due course.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 10120 question first answered 17/09/2015 15:53:58 answering member 3918 label Biography information for Jane Ellison
	tabling member	308 label Biography information for Mr Jim Cunningham

348416

	registered interest
	date	03/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Social Security Benefits: Medical Examinations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate his Department has made of the cost to NHS England of the provision of fitness for work certificates as required by the Department for Work and Pensions in the period 2014-15.
	tabling member constituency	Denton and Reddish
	tabling member printed	Andrew Gwynne
	uin	1022
	answer	answer is ministerial correction date of answer 11/06/2015 answer text <p>Neither the Department nor NHS England has made any assessment of the cost of the provision of fitness for work certificates.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/06/2015 10:50:06 answering member 3918 label Biography information for Jane Ellison
	tabling member	1506 label Biography information for Andrew Gwynne